The official blog of the Lung Institute.

The Lung Institute Now Treats Pneumoconiosis

21 May 2015
| Under Press | Posted by
Pneumonconiosis Lung Institute

Sufferers of conditions like black lung disease are finally breathing easier.

Tampa, FL (May 21, 2015)Pneumoconiosis is a debilitating lung disease caused by breathing in the particles of mineral dust. It is an occupational lung disease common among miners, welders, tunnel builders and other manufacturing positions. Oftentimes, symptoms don’t present themselves immediately, so by the time someone shows symptoms, the damage has already been done. Symptoms of pneumoconiosis include: increased mucus, chronic cough, shortness of breath, pulmonary hypertension, chest tightness/pain, heart problems and cyanosis. Unfortunately, there isn’t a cure for this condition, and traditional treatment options have been limited to things like oxygen therapy.

Many workers have been frustrated with current and past employers due to the lack of compensation for these costly medical conditions, which often yield little results. Now, cellular therapy offers another option for these workers to finally breathe easier. The Lung Institute is pleased to announce that they are now able to offer treatments for those suffering from pneumoconiosis.

There are three types of pneumoconiosis: black lung, silicosis and siderosis. All three conditions involve inhaling particles into the lungs, which settle and cause severe irritation. This irritation slowly causes scarring to the lung tissue, which causes it to harden and ultimately makes it harder for a person to breathe. As a result, sufferers are at risk for heart failure, pulmonary tuberculosis, respiratory failure and death.

Cellular therapy has helped many lung disease sufferers regain their quality of life. While cellular therapy isn’t a cure, it helps bring a more normal life back into reach. With some Cellular therapy patients being able to do things like shower on their own, walk to the mailbox without oxygen, golf, travel and more—things that they thought they would never be able to do after being diagnosed with pneumoconiosis or another debilitating lung disease.

Lung Institute patient Arnold M. explains the results that he has experienced after receiving cellular therapy treatments: “I can walk about 200-300 feet. Prior to this I could only walk 20 feet. The other day, I had two appointments. One was for my lung doctor, a pulmonologist, and the other one was with the eye doctor. The pulmonologist said, ‘You seem to be doing real well; what have you been doing lately?’ I said that I’ve just been taking care of myself, and he goes ‘My god, you’ve been doing a good job.’ He couldn’t believe I was that good; I told him about cells, and he stood there with his mouth hanging open. I guess he didn’t run across anybody that has done it. He was kind of amazed.”

The Lung Institute has completed over 800 cellular therapy treatments to date and is excited to now be able to treat those suffering from pneumoconiosis. The Lung Institute currently has clinics in Tampa, Scottsdale and Nashville, they look forward to opening a fourth clinic in Pittsburgh in July 2015.

About the Lung Institute

At the Lung Institute, we are changing people’s lives across the nation through the innovative technology of regenerative medicine. We recognize the challenges of finding effective and sustainable treatment options for patients who might be suffering from debilitating lung diseases, and we are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life. Our goal is to help patients breathe easier and bring life back within reach. For more information, visit our website at LungInstitute.com, like us on Facebook, follow us on Twitter or call us today at 888-745-6697.

*For more information, go to www.LungInstitute.com/Results.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.